Measurable disease as defined by RECIST v.
Patient much have measurable disease as defined by RECIST .
Measurable disease as defined by RECIST v.
Measurable disease, as defined by RECIST v.
SAFETY RUN-IN: Have either evaluable disease, or have measurable clinical disease: measurable disease, defined as at least  unidimensionally measurable lesion on a computed tomography (CT) scan as defined by RECIST (version v.)
RANDOMIZED PHASE II CLINICAL TRIAL: Have measurable clinical disease: Measurable disease, defined as at least  unidimensionally measurable lesion on a CT scan as defined by RECIST (version v.)
Measurable disease as defined by RECIST
Measurable disease as defined by RECIST . is required (Part )
Participants must have measurable extracranial disease as defined by RECIST .
One or more tumors measurable on radiographic imaging as defined by RECIST ..
Measurable disease, as defined by RECIST v.
Participant must have measurable disease outside the field of radiation as defined by RECIST .
Part B (all cohorts): Have the presence of measurable disease as defined by the RECIST ..
Measurable disease, defined as per RECIST . criteria
Measurable disease, as defined by RECIST v.
Measurable disease as defined by RECIST .
Measurable disease as defined by RECIST .
Measurable or non-measurable disease, as defined by RECIST .
Measurable disease as defined by RECIST v.
Most recent imaging shows measurable disease as defined by RECIST .
Have measurable clinical disease: measurable disease, defined as at least  measurable lesion on a computed tomography (CT) scan as defined by RECIST (version v.)
Patients must have measurable disease as defined by RECIST v.
Radiologically measurable disease in the pancreas >=  cm, as defined by RECIST v.
Patients must have measurable disease as defined by RECIST (see Section ).
All patients must have measurable disease as defined by RECIST .; patients must also have evidence of disease progression by RECIST . within  months of first dose of study drug
Subjects must have measurable disease as defined by RECIST .
Patients may have measurable or non-measurable disease as defined by RECIST ..
Measurable disease as defined by RECIST . Criteria.
Patients may have measurable or non-measurable disease as defined by RECIST ..
Measurable disease defined by RECIST criteria
Patients must have measurable disease as defined by RECIST . criteria
Absence of RECIST, v. . defined measurable disease.
Patients must measurable disease, as defined by RECIST . criteria
Subjects must have measurable disease as defined by RECIST .
Measurable disease as defined by RECIST .
Radiographically documented measurable disease at study entry (as defined by the RECIST v. criteria).
Measurable/assessable disease, as defined by RECIST v..
Measurable disease, as defined by RECIST v.
Patients must have measurable disease as defined by RECIST ..
Measurable disease as defined by RECIST .
Measurable disease as defined by modified RECIST for MPM (Byrne and Nowak, )
Measurable disease as defined by RECIST v.
Measurable disease as defined by RECIST .
Measurable non-CNS disease, defined by RECIST . criteria
Measurable disease as defined by RECIST ..
Patients must have measurable disease, defined by RECIST .
Presence of radiographically measurable disease as defined by RECIST .
Patients must have one or more tumors measurable on radiographic imaging as defined by RECIST.
Measurable disease, as defined by RECIST v.
Measurable disease, as defined by RECIST v.
Measurable disease as defined by RECIST . criteria;
Measurable disease, as defined by RECIST v .
Measurable disease as defined by RECIST Criteria.
Measurable disease as defined by RECIST v.
Must have measurable disease as defined by RECIST ..
Measurable disease as defined by RECIST . criteria
Measurable disease, defined as at least  unidimensionally measurable lesion on a computed tomography (CT) scan as defined by RECIST .
Measurable disease as defined by RECIST v.
Measurable disease as defined by RECIST v.
Patients must have measurable disease defined by RECIST criteria ..
Measurable disease defined by RECIST v.
Measurable disease as defined by the RECIST v..
Patient must have measurable disease as defined by RECIST ..
Measurable disease, as defined by RECIST . criteria;
Measurable disease as defined by RECIST v.
Measurable disease as defined by RECIST . within  days prior to registration
Measurable disease, as defined by RECIST v.
Presence of measurable or non-measurable lesions as defined by irRC-RECIST
